In summary, our Pan-Cancer analysis of human tumor data indicates NOX4 can contribute to several gene expression programs that promote cancer progression in many tumor types with common TP53 mutations, and that TP53 mutations could “switch” NOX4 from being protective and an indicator of good prognosis to deleterious outcomes of cancer progression. Here, NOX4 is linked to cancer.